Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Escalon MedicalESMC 34 PB Ratio is 0.42 as of Jul. 23, 2026, which is 59% below its 10-year median of 1.03. GuruFocus rates ESMC with a GF Score™ of 34/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Escalon Medical ranks better than 94.27% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-23), Escalon Medical's share price is $0.20. Escalon Medical's Book Value per Share for the quarter that ended in Mar. 2026 was $0.47. Hence, Escalon Medical's PB Ratio of today is 0.42.
The historical rank and industry rank for Escalon Medical's PB Ratio or its related term are showing as below:
ESMC'
s PB Ratio Range Over the Past 10 Years
Min: 0.29 Med: 1.03 Max: 4.94
Current: 0.43
During the past 13 years, Escalon Medical's highest PB Ratio was 4.94. The lowest was 0.29. And the median was 1.03.
ESMC's PB Ratio is ranked better than 94.27% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs ESMC: 0.43
During the past 12 months, Escalon Medical's average Book Value Per Share Growth Rate was 111.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 10.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -7.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Escalon Medical was 66.50% per year. The lowest was -62.90% per year. And the median was -9.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Escalon Medical PB Ratio Related Terms
Escalon Medical PB Ratio Historical Data
* Premium members only.
The historical data trend for Escalon Medical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Escalon Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Escalon Medical PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Escalon Medical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Escalon Medical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Escalon Medical (ESMC) has a PB Ratio of 0.42 as of Jul. 23, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Escalon Medical and its competitors. This is 59% below median its historical median of 1.03. Over the past decade, Escalon Medical's PB Ratio has ranged from 0.29 to 4.94. According to the industry distribution chart, Escalon Medical ranks #45 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 5.7%.
Is Escalon Medical's PB Ratio too high?
Escalon Medical's current PB Ratio of 0.42 is 59% below median its 10-year median of 1.03. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 4.94. The Medical Devices & Instruments industry median PB Ratio is 2.05. Escalon Medical's value of 0.42 is 79.5% below this industry median. Based on the distribution chart, Escalon Medical ranks #45 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Escalon Medical has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Escalon Medical's PB Ratio compare to RBOT and NUWE?
According to the Medical Devices & Instruments industry distribution chart, Escalon Medical ranks #45 out of 786 companies for PB Ratio. This places Escalon Medical in the top 6% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.05. Escalon Medical's value of 0.42 is 79.5% below this benchmark. Historically, Escalon Medical's own PB Ratio has ranged from 0.29 to 4.94 over the past decade. While the company's 10-year median is 1.03 vs. the industry median of 2.05, Escalon Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Escalon Medical's current PB Ratio of 0.42 is 79.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Escalon Medical and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Escalon Medical's current PB Ratio is 0.42, which is 59% below median its own 10-year median of 1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Escalon Medical stock overvalued right now?
Based on GuruFocus' analysis, Escalon Medical (ESMC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $0.20 — trading 33.3% above its estimated fair value. The current PB Ratio is 0.42, which is 59% below median its 10-year median of 1.03 and 79.5% below the Medical Devices & Instruments industry median of 2.05. Escalon Medical's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Escalon Medical (ESMC), the current PB Ratio is 0.42 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Escalon Medical (ESMC) Overvalued in 2026?
Based on GuruFocus' analysis, Escalon Medical stock appears to be overvalued.
The current stock price of $0.20 is trading 33.3% above its estimated GF Value™ of $0.15.
GuruFocus considers Escalon Medical to be Significantly Overvalued.
Key valuation signals for ESMC:
PB Ratio: 0.42 (59% below median its 10-year median of 1.03)
GF Value™: $0.15 vs. price of $0.20 (33.3% above fair value)
Industry Position: 79.5% below the Medical Devices & Instruments median (#45 of 786)
No single metric tells the full story. See the ESMC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Escalon Medical Corp operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.
34GF Score
Get the complete analysis for ESMC
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESMC has been successfully added to your 
